Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combination therapy for myelomatosis.

L Azam, I W Delamore

    British Medical Journal
    |December 7, 1974
    PubMed
    Summary

    This study shows a quadruple chemotherapy regimen, including BCNU, cyclophosphamide, melphalan, and prednisolone, is effective for multiple myeloma. The treatment demonstrated superior results compared to previous regimens with a low mortality rate.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Developmental regulation of nicotinic acetylcholine receptors within midbrain dopamine neurons.

    Neuroscience·2007
    Same author

    Co-expression of alpha7 and beta2 nicotinic acetylcholine receptor subunit mRNAs within rat brain cholinergic neurons.

    Neuroscience·2003
    Same author

    New enzyme immunoassay for detecting total, type I, and type II intrinsic factor antibodies.

    Journal of clinical pathology·1989
    Same author

    The influence of anticoagulant on the in vitro level and stability of factor VIII procoagulant activity.

    Thrombosis research·1987
    Same author

    Inhibition of normal human granulopoiesis in vitro by amiloride: evidence for the involvement of facilitated sodium influx in the induction of differentiation.

    Leukemia research·1987
    Same author

    Systemic infection with Aureobasidium pullulans in a leukaemic patient.

    The Journal of infection·1986

    Area of Science:

    • Oncology
    • Hematology
    • Pharmacology

    Background:

    • Multiple myeloma is a hematologic malignancy requiring effective treatment regimens.
    • Previous single-agent therapies have shown limited success in managing multiple myeloma.
    • The development of combination chemotherapy offers potential for improved patient outcomes.

    Purpose of the Study:

    • To evaluate the efficacy of a novel quadruple chemotherapy regimen for multiple myeloma.
    • To assess treatment response across eight predefined criteria.
    • To determine the safety and survival impact of the quadruple regimen.

    Main Methods:

    • A cohort of 28 multiple myeloma patients was treated with a quadruple regimen.
    • The regimen included 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), cyclophosphamide, melphalan, and prednisolone.
    • Patients included newly diagnosed individuals and those with prior treatment failure.

    Main Results:

    • The quadruple chemotherapy regimen demonstrated superior efficacy compared to previous regimens.
    • Positive responses were observed across eight criteria of efficacy.
    • The study reported a low mortality rate, with only three deaths in 18 months.

    Conclusions:

    • The quadruple chemotherapy regimen, incorporating BCNU, cyclophosphamide, melphalan, and prednisolone, shows significant promise in treating multiple myeloma.
    • This combination therapy appears to offer improved outcomes and a favorable safety profile.
    • Further investigation into this regimen is warranted for advanced multiple myeloma treatment.

    Related Experiment Videos